Carnegie Mellon University v. LSI Corporation

CourtDistrict Court, N.D. California
DecidedAugust 12, 2025
Docket3:18-cv-04571
StatusUnknown

This text of Carnegie Mellon University v. LSI Corporation (Carnegie Mellon University v. LSI Corporation) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carnegie Mellon University v. LSI Corporation, (N.D. Cal. 2025).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 CARNEGIE MELLON UNIVERSITY, Case No. 18-cv-04571-JD

8 Plaintiff, CLAIM CONSTRUCTION v. 9

10 LSI CORPORATION, et al., Defendants. 11

12 13 The parties in this long-running patent infringement action, plaintiff Carnegie Mellon 14 University (CMU) and defendants LSI Corp. and Avago Technologies (together LSI), have asked 15 for construction of seven terms or phrases in U.S. Patent No. 6,201,839 (the ’839 patent) and U.S. 16 Patent No. 6,438,180 (the ’180 patent). The parties’ familiarity with the record is assumed. 17 Construction of two disputed terms -- “Viterbi-like algorithm” and “each sample corresponds to a 18 different sampling time instant” -- is deferred to summary judgment because LSI raises 19 indefiniteness challenges. The other five disputed terms are construed. 20 LEGAL STANDARD 21 “Claim construction must begin and remain centered on the claim language itself, for that 22 is the language the patentee has chosen to particularly point out and distinctly claim the subject 23 matter which the patentee regards as his invention.” Hybrid Audio, LLC v. Asus Comp. Int’l Inc., 24 No. 17-cv-05947-JD, 2022 WL 3348594, at *1 (N.D. Cal. Aug. 12, 2022) (cleaned up) (quoting 25 Source Vagabond Sys. Ltd. v. Hydrapak, Inc., 753 F.3d 1291, 1299 (Fed. Cir. 2014)). Claim terms 26 are given their “ordinary and customary meaning,” which is “the meaning that the term would 27 have to a person of ordinary skill in the art in question at the time of the invention.” Broadcom 1 Corp. v. Netflix Inc., No. 20-cv-04677-JD, 2022 WL 1619151, at *1 (N.D. Cal. May 23, 2022) 2 (quoting Phillips v. AWH Corp., 415 F.3d 1303, 1312-13 (Fed. Cir. 2005) (en banc)). 3 The Federal Circuit has emphasized that the “only meaning that matters in claim 4 construction is the meaning in the context of the patent.” Trustees of Columbia Univ. v. Symantec 5 Corp., 811 F.3d 1359, 1363 (Fed. Cir. 2016). “The presumption in favor of giving terms their 6 plain and ordinary meaning may be overcome by a patentee’s express definition of a term, or 7 express disavowal of the scope of the claim.” Broadcom, 2022 WL 1619151, at *2. “A term may 8 be redefined ‘by implication’ when given a meaning that is ascertainable from a reading of the 9 specification or the patent documents.” Hybrid Audio, 2022 WL 3348594, at *2 (citation 10 omitted). “The ordinary meaning of a claim term is not the meaning of the term in the abstract,” 11 but the term’s “meaning to the ordinary artisan after reading the entire patent.” Astra Zeneca AB 12 v. Mylan Pharm. Inc., 19 F.4th 1325, 1330 (Fed. Cir. 2021) (quotations and citations omitted). 13 “A claim and its constituent words and phrases are interpreted in light of the intrinsic 14 evidence. The touchstones are the claims themselves, the specification, and, if in evidence, the 15 prosecution history.” Hybrid Audio, 2022 WL 3348594, at *2. “This intrinsic evidence is the 16 most significant source of the legally operative meaning of disputed claim language.” Id. (citing 17 Vitronics Corp. v. Conceptronic, Inc., 90 F.2d 1576, 1582 (Fed. Cir. 1996)). Although “reading a 18 limitation from the written description into the claims is one of the cardinal sins of patent law,” 19 Broadcom Corp. v. Netflix Inc., 762 F. Supp. 3d 878, 884 (N.D. Cal. 2025) (cleaned up) (quoting 20 Phillips, 415 F.3d at 1320), “the specification is ‘the single best guide to the meaning of a disputed 21 term,’” Broadcom, 2022 WL 1619151, at *2 (citation omitted); see also Merck & Co., Inc. v. Teva 22 Pharms. USA, Inc., 347 F.3d 1367, 1370 (Fed. Cir. 2003) (“[C]laims must be construed so as to be 23 consistent with the specification . . . .”). “The Court may also use extrinsic evidence (e.g., 24 dictionaries, treatises) to resolve the scope and meaning of a claim as circumstances warrant.” 25 Broadcom, 2022 WL 1619151, at *2. 26 CLAIM CONSTRUCTION 27 The parties request construction of terms in Claim 4 of the ’839 patent and Claim 2 of the 1 Claim 4, ’839 patent:

2 A method of determining branch metric values for branches of a trellis for a Viterbi-like detector, comprising: 3 selecting a branch metric function for each of the branches at a certain time index from a set of signal-dependent branch 4 metric functions; and applying each of said selected functions to a plurality of signal 5 samples to determine the metric value corresponding to the branch for which the applied branch metric function was 6 selected, wherein each sample corresponds to a different sampling time instant. 7 8 Claims 1 and 2, ’180 patent1: 9 A method of determining branch metric values in a detector, 10 comprising: receiving a plurality of time variant signal samples, the signal 11 samples having one of signal-dependent noise, correlated noise, and both signal dependent and correlated noise 12 associated therewith; selecting a branch metric function at a certain time index; and 13 applying the selected function to the signal samples to determine the metric values. 14 The method of claim 1, wherein the branch metric function is selected 15 from a set of signal-dependent branch metric functions. 16 The parties agree the relevant person of ordinary skill in the art (POSITA) here is an 17 individual who, as of 1998, held a Master’s degree in electrical engineering and had at least two 18 years of experience in the industry, and who specialized or had experience in data-detection 19 techniques or technologies. Dkt. Nos. 144-4 (McLaughlin Decl.)2 ¶¶ 57-58; 144-5 (Soljanin 20 Rebuttal Decl.) ¶¶ 23-24; see In re GPAC Inc., 57 F.3d 1573, 1579 (Fed. Cir. 1995) (“The person 21 of ordinary skill in the art is a hypothetical person who is presumed to know the relevant prior 22 art.”). The ensuing constructions draw on this framing of the POSITA. 23 24 25

26 1 The Court is construing a term that appears only in Claim 2, but Claim 1 is included for context.

27 2 Dkt. No. 144-4 contains both an affirmative declaration and rebuttal declaration from Dr. Steven 1 A. “branch metric function” (Claim 2 of the ’180 patent & Claim 4 of the ’839 patent) 2 3 CMU’s Proposed LSI’s Proposed Court’s Construction 4 construction Construction 5 A function for determining a A mathematical relation that A mathematical function for 6 branch metric value for a uniquely associates signal determining a branch metric 7 branch, where the first set of samples with branch metric value for a branch, where a 8 the function comprises one or values. “function” is a mathematical 9 more signal samples and one relation that uniquely 10 or more target values, and the associates members of a first 11 second set comprises branch set with members of a second 12 metric values. set. 13 Although not binding, the Court “would be remiss to overlook another district court’s 14 construction of the same claim terms in the same patent.” Finisar Corp. v. DirecTV Grp., Inc., 15 523 F.3d 1323, 1329 (Fed. Cir. 2008). In a prior litigation, Carnegie Mellon University v. Marvell 16 Technology Group, Ltd.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paragon Solutions, LLC v. Timex Corp.
566 F.3d 1075 (Federal Circuit, 2009)
Finisar Corp. v. DirecTV Group, Inc.
523 F.3d 1323 (Federal Circuit, 2008)
In Re GPAC Inc.
57 F.3d 1573 (Federal Circuit, 1995)
Comark Communications, Inc. v. Harris Corporation
156 F.3d 1182 (Federal Circuit, 1998)
Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd.
715 F.3d 1363 (Federal Circuit, 2013)
Source Vagabond Systems Ltd. v. Hydrapak, Inc.
753 F.3d 1291 (Federal Circuit, 2014)
Trustees of Columbia Univ. v. Symantec Corporation
811 F.3d 1359 (Federal Circuit, 2016)
Astrazeneca Ab v. Mylan Pharmaceuticals Inc.
19 F.4th 1325 (Federal Circuit, 2021)
Superguide Corp. v. DirecTV Enterprises, Inc.
358 F.3d 870 (Federal Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Carnegie Mellon University v. LSI Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/carnegie-mellon-university-v-lsi-corporation-cand-2025.